Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.35 |
| ▸ | HTR6 known ✓ | P50406 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL716020 | 1.00 | HTR2A (0.35) | HTR2AHTR6KDM4EMEN1PMP22 | |
| Hydrochloric Acid SCHEMBL8032417 | 1.00 | HTR2A (0.35) | HTR2AHTR6KDM4EMEN1PMP22 | |
| Hydrochloric Acid SCHEMBL6914264 | 0.98 | HTR2A (0.34) | HTR2AHTR6KDM4EMEN1PMP22 | |
| Bromide SCHEMBL6918049 | 0.98 | HTR2A (0.34) | HTR2AHTR6KDM4EMEN1PMP22 | |
| SCHEMBL812866 | 0.98 | HTR2A (0.36) | HTR2AHTR6KDM4E | |
| SCHEMBL285579 | 0.98 | HTR2A (0.36) | HTR2AHTR6KDM4E | |
| Bromide SCHEMBL6907653 | 0.96 | HTR2A (0.35) | HTR2AHTR6 | |
| SCHEMBL8754698 | 0.96 | HTR2A (0.35) | HTR2AHTR6 | |
| Methane SCHEMBL5839744 | 0.96 | HTR2A (0.35) | HTR2AHTR6 | |
| Bromide SCHEMBL818948 | 0.96 | HTR2A (0.35) | HTR2AHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8329841-B2 | Photoreactive polymer and method for preparing the same | LG CHEM, LTD. (KR) | 2012-12-11 | — | — | US | claimed |
| US-20120149848-A1 | PHOTOREACTIVE POLYMER AND METHOD FOR PREPARING THE SAME | LG CHEM, LTD. (KR) | 2012-06-14 | — | — | US | claimed |
| EP-1799726-B1 | TRIALKYLALUMINUM TREATED SUPPORTS | EXXONMOBIL CHEM PATENTS INC (US) | 2011-07-13 | — | — | EP | claimed |
| US-7741417-B2 | Preparation of polymerization catalyst activators utilizing indole-modified silica supports | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-06-22 | — | — | US | claimed |
| US-20100093955-A1 | PHOTOREACTIVE POLYMER AND METHOD FOR PREPARING THE SAME | LG CHEM, LTD. (KR) | 2010-04-15 | — | — | US | claimed |
| WO-2008115028-A9 | PHOTOREACTIVE POLYMER AND METHOD FOR PREPARING THE SAME | LG CHEMICAL LTD (KR) | 2008-12-18 | — | — | WO | claimed |
| WO-2008115028-A1 | PHOTOREACTIVE POLYMER AND METHOD FOR PREPARING THE SAME | LG CHEM, LTD. (KR) | 2008-09-25 | — | — | WO | claimed |
| US-7385015-B2 | Trialkylaluminum treated supports | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-06-10 | — | — | US | claimed |
| US-7220695-B2 | Supported activator | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-05-22 | — | — | US | claimed |
| US-20070055028-A1 | Preparation of polymerization catalyst activators utilizing indole-modified silica supports | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-03-08 | — | — | US | claimed |
| US-20060079394-A1 | Trialkylaluminum treated supports | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-04-13 | — | — | US | claimed |
| US-20050148743-A1 | polymerization catalyst systems comprising an ion-exchange layered silicate, an organoaluminum compound, and a heterocyclic compound | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-07-07 | — | — | US | claimed |
| EP-1131360-B1 | PROCESS FOR THE POLYMERIZATION OF AN OLEFIN, METALLOCENE CATALYST THEREFOR AND COCATALYST FOR ACTIVATING A METALLOCENE PROCATALYST | UNIROYAL CHEM CO INC (US) | 2004-11-24 | — | — | EP | claimed |
| EP-1090047-B1 | POLYMERIZATIONS USING ADJUVANT CATALYST | HUNTSMAN POLYMERS CORP (US) | 2004-08-04 | — | — | EP | claimed |
| EP-0619325-B1 | Process for preparing polyolefin catalysts | ATOFINA RES (BE) | 2001-08-29 | — | — | EP | claimed |
| EP-0789624-B1 | PROCESS FOR PRODUCING BIOMODAL MOLECULAR WEIGHT DISTRIBUTION ETHYLENE POLYMERS AND COPOLYMERS | MOBIL OIL CORP (US) | 2000-03-22 | — | — | EP | claimed |
| EP-0824554-B1 | AMORPHOUS OLEFIN CO/TER-POLYMERS | OPTATECH CORP (FI) | 2000-03-01 | — | — | EP | claimed |
| EP-0720989-B1 | Continuous process for the (co)polymerization of ethylene | ENICHEM SPA (IT) | 1999-09-01 | — | — | EP | claimed |
| EP-0283164-B1 | Cyclo-olefinic random copolymer, olefinic random copolymer, and process for producing cyclo-olefinic random copolymers | MITSUI PETROCHEMICAL IND (JP) | 1995-05-24 | — | — | EP | claimed |
| EP-0294942-B1 | Solid catalyst for polymerizing an olefin | MITSUI PETROCHEMICAL IND (JP) | 1994-07-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149848-A1 | PHOTOREACTIVE POLYMER AND METHOD FOR PREPARING THE SAME | PCNA, LCP1, CCND2 | HTR2A 3002/4885HTR6 3377/4885KDM4E 1938/4885 |
| US-20100093955-A1 | PHOTOREACTIVE POLYMER AND METHOD FOR PREPARING THE SAME | PCNA, LCP1, CCND2 | HTR2A 3002/4885HTR6 3377/4885KDM4E 1938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.